Mean Change From Baseline in the Total Ocular Symptom Score (TOSS) Over the Entire Treatment Period, at Week 1, and at Week 2 [ Time Frame: Baseline through the entire treatment period (2 weeks), Week 1, and Week 2 ] [ Designated as safety issue: No ]
Symptoms of eye itching, tearing, and redness were scored by the participant's parent/guardian who signed the ICF or the participant themself using a scale of 0, 1, 2, or 3 (a larger score indicates more severe symptoms) and were recorded in the participant's diary
https://clinicaltrials.gov/ct2/show/NCT01630135